We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
176
Fortive
FTV
$19B
$42.7M 0.17%
804,696
-85,345
-10% -$4.38M
HST icon
177
Host Hotels & Resorts
HST
$16.8B
$42.4M 0.17%
2,011,121
-134,963
-6% -$2.85M
OUT icon
178
Outfront Media
OUT
$5.64B
$42.3M 0.17%
+2,155,014
New +$42.8M
GIS icon
179
General Mills
GIS
$19.2B
$42.1M 0.17%
982,018
+180,093
+22% +$8.15M
ALLY icon
180
Ally Financial
ALLY
$13.1B
$42.1M 0.17%
1,593,018
+1,510,537
+1,831% +$41M
NTGR icon
181
NETGEAR
NTGR
$669M
$42M 0.17%
667,599
-86,578
-11% -$5.92M
HELE icon
182
Helen of Troy
HELE
$663M
$41.7M 0.17%
318,858
-95,269
-23% -$11.2M
SNA icon
183
Snap-on
SNA
$20.9B
$41.7M 0.17%
227,055
+82,201
+57% +$14.3M
HAL icon
184
Halliburton
HAL
$27.9B
$41.3M 0.17%
1,018,596
+507,563
+99% +$21M
TTMI icon
185
TTM Technologies
TTMI
$13.6B
$41.3M 0.17%
2,593,370
-21,632
-0.8% -$387K
KLAC icon
186
KLA
KLAC
$275B
$41.2M 0.16%
4,049,000
+1,688,630
+72% +$18.5M
DOX icon
187
Amdocs
DOX
$5.53B
$41.1M 0.16%
622,887
-52,952
-8% -$3.5M
FITB
188
Fifth Third Bancorp
FITB
$52B
$41M 0.16%
1,470,226
-126,708
-8% -$3.72M
MPC icon
189
Marathon Petroleum
MPC
$90.3B
$41M 0.16%
512,628
-31,829
-6% -$2.52M
USMV icon
190
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$40.9M 0.16%
+717,566
New +$40M
VNDA icon
191
Vanda Pharmaceuticals
VNDA
$312M
$40.5M 0.16%
1,766,746
+1,766,208
+328,291% +$36.1M
FCB
192
DELISTED
FCB Financial Holdings, Inc.
FCB
$40.5M 0.16%
855,148
-24,813
-3% -$1.31M
OXM icon
193
Oxford Industries
OXM
$577M
$40.4M 0.16%
447,942
-53,899
-11% -$4.9M
AIR icon
194
AAR Corp
AIR
$5.15B
$40.2M 0.16%
840,111
+141,262
+20% +$6.49M
TVTY
195
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$40.2M 0.16%
1,251,426
-36,307
-3% -$1.24M
ORA icon
196
Ormat Technologies
ORA
$6.11B
$40.1M 0.16%
741,453
+224,256
+43% +$11.9M
EFII
197
DELISTED
Electronics for Imaging
EFII
$40M 0.16%
1,173,120
-34,095
-3% -$1.16M
KMI icon
198
Kinder Morgan
KMI
$73.1B
$39.7M 0.16%
2,240,616
+1,978,949
+756% +$35.4M
LUV icon
199
Southwest Airlines
LUV
$22.1B
$39.5M 0.16%
632,347
-492,804
-44% -$28.8M
MXL icon
200
MaxLinear
MXL
$6.49B
$39.2M 0.16%
1,971,057
-57,171
-3% -$1.04M

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.